The duration of treatment varies by patient
The authors caution that GLP-1RAs should not be viewed as standalone solutions but as one component of a broader treatment approach that includes psychological support
published third-party studies after GLP-1 withdrawal alone have shown ~15% weight regain at similar time points 33% of patients continued to lose further weight one year after discontinuing a GLP-1 Next anticipated Revita clinical data readouts are one-year randomized data from the REMAIN-1 Midpoint Cohort in Q3 2026 and topline six-month randomized data from the REMAIN-1 Pivotal Cohort in early Q4 2026 BURLINGTON, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc
If it has become stale or is poorly managed, it adds little value
LUPKIN: Let's talk about the pill made by Novo Nordisk, whose active ingredient is semaglutide
At MyTeleHealthPoint , we help you reach your weight loss goals through trusted, doctor-led care from the comfort of your home